Cross Country Health/ US2274831047 /
| 2024-05-01 6:45:39 PM | Chg. +0.2900 | Volume | Bid6:46:06 PM | Ask6:46:06 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 17.8900USD | +1.65% | 146,367 Turnover: 1.82 mill. |
17.8600Bid Size: 200 | 17.9100Ask Size: 200 | 622.28 mill.USD | - | 8.66 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 11.8320 | 12.3510 | 15.8330 | 19.6620 | 27.3390 | ||||||
| Intangible Assets | 44.9570 | 34.8310 | 42.3440 | 44.7230 | 54.4680 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 199.0170 | 173.8620 | 224.5360 | 272.1660 | 264.1640 | ||||||
| Inventories | - | - | - | - | - | ||||||
| Accounts Receivable | 169.5280 | 170.0030 | 493.9100 | 641.6110 | 372.3520 | ||||||
| Cash and Cash Equivalents | 1.0320 | 1.6000 | 1.0360 | 3.6040 | 17.0940 | ||||||
| Current Assets | 183.3570 | 183.1110 | 508.2730 | 675.6730 | 415.1530 | ||||||
| Total Assets | 382.3740 | 356.9730 | 732.8090 | 947.8390 | 679.3170 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | - | - | - | - | - | ||||||
| Long-term debt | 70.9740 | 53.4080 | 176.3660 | 148.7350 | 0.0000 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 7.5000 | - | - | - | - | ||||||
| Liabilities | 218.8740 | 202.0640 | 435.2810 | 490.6200 | 205.9240 | ||||||
| Share Capital | .0040 | .0040 | .0040 | .0040 | .0040 | ||||||
| Total Equity | 163.5000 | 154.9090 | 297.5280 | 457.2190 | 473.3930 | ||||||
| Minority Interests | .8680 | .5340 | 0.0000 | 0.0000 | - | ||||||
| Total liabilities equity | 382.3740 | 356.9730 | 732.8090 | 947.8390 | 679.3170 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 822.2240 | 836.4170 | 1,676.6520 | 2,806.6090 | 2,019.7280 | ||||||
| Depreciation (total) | 14.0750 | 12.6710 | 9.8520 | 12.5760 | 18.3470 | ||||||
| Operating Result | -15.7110 | -9.1600 | 139.3040 | 273.1080 | 112.7130 | ||||||
| Interest Income | 5.3060 | 2.8900 | 6.8660 | 14.3910 | 8.0940 | ||||||
| Income Before Taxes | -24.2110 | -12.3300 | 133.2080 | 256.3250 | 102.8940 | ||||||
| Income Taxes | 31.7320 | -.1880 | 1.2060 | 67.8640 | 30.2630 | ||||||
| Minority Interests Profit | 1.7700 | .8200 | 0.0000 | 0.0000 | - | ||||||
| Net Income | -57.7130 | -12.9620 | 132.0020 | 188.4610 | 72.6310 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 5.5420 | 27.2040 | -85.6180 | 134.0500 | 248.4980 | ||||||
| Cash Flow from Investing Activities | -2.9400 | -4.6150 | -34.0460 | -43.8740 | -13.7750 | ||||||
| Cash Flow from Financing | -17.5990 | -22.0100 | 119.0940 | -87.5990 | -221.2410 | ||||||
| Decrease / Increase in Cash | -14.9870 | .5680 | -.5640 | 2.5680 | 13.4900 | ||||||
| Employees | 1,700 | - | - | - | - | ||||||
